Gefitinib

ADVERTISEMENT

Identification

Molecular formula
C22H24ClFN4O3
CAS Number
184475-35-2
IUPAC Name
5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine
Molecular Weight
446.91g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.4215g/cm3
Synonyms
trimetrexate
Interesting facts

Interesting Facts about 5-Methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine

This intriguing compound, with a complex structure, is a member of the quinazoline family, which is renowned for its diverse biological activities. Here are some fascinating insights:

  • Pharmaceutical Potential: Quinazoline derivatives have been investigated for their potential in treating various diseases, including cancers and neurological disorders. This particular compound may exhibit significant therapeutic properties worth exploring.
  • Structural Features: The compound showcases a quinazoline core, which is often characterized by a fused bicyclic structure. This particular configuration is often pivotal in enabling the molecule to interact with biological targets.
  • Substituent Influence: The presence of the 3,4,5-trimethoxyanilino group adds to the compound's unique properties. The methoxy groups can enhance solubility and alter biological activity, making this compound a subject of interest in medicinal chemistry.
  • Research Applications: Scientists have identified similar compounds involved in enzyme inhibition and receptor binding. Therefore, this compound may pave the way for new drug development by acting as a prototype for further modifications and studies.

As researchers continue to explore and synthesize novel derivatives, understanding the intricate balance of structure and function in compounds like this one is crucial. The innovative designs in medicinal chemistry can lead to groundbreaking discoveries that benefit human health.

To quote the famous chemist Linus Pauling, “The best way to have a good idea is to have a lot of ideas.” This compound serves as a reminder of the endless possibilities that exist at the molecular level in drug design and development.

ADVERTISEMENT